Trial Profile
Clinical Trials Insight: 700009583
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jan 2010
Price :
$35
*
At a glance
- Drugs MEM 1003 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Memory Pharmaceuticals
- 01 Dec 2005 New trial record.